Fannie Mae has filed with the U.S. Securities and Exchange Commission that the GSE has notified the New York Stock Exchange that it intends to bring the share price of its common stock and the average share price of its common stock for 30 consecutive trading days above $1.00 by no later than May 11, 2009. Fannie Mae is currently working with its conservator, the Federal Housing Finance Agency, to determine the specific action or actions that Fannie Mae will take to cure the deficiency. If necessary to bring its share price and its average share price for 30 consecutive trading days above $1.00, and subject to the approval of the U.S. Department of Treasury, Fannie Mae has advised the NYSE that it may undertake a reverse stock split in order to cure the deficiency by the May 11, 2009 date. Fannie Mae expects to determine the actual number of shares that will produce one share of common stock as a result of any reverse stock split based on both the market price of Fannie Mae's common stock prior to announcement of the split and additional input from FHFA and Treasury. Under applicable NYSE rules, Fannie Mae now has until May 11, 2009, subject to supervision by the NYSE, to bring its share price and its average share price for 30 consecutive trading days above $1.00. If it fails to do so, the NYSE will initiate suspension and delisting procedures.
-
A memo from Fannie Mae and Freddie Mac has separate links for each company's form to ask for the policy exception for compliance with the Nov. 2 deadline.
1h ago -
Better must formally accept the proxy results, which would move forward the founder's plan to reshape the board of directors and tap a new interim CEO.
3h ago -
Nearly 21% of the homes for sale were reduced in price during September, the highest for the month on record, while inventory grew over 5%, Realtor.com noted.
3h ago -
Home value fell in real terms, as inflation ran 1.5 percentage points above price growth, down slightly from 3.5% in June, according to the Case-Shiller index.
3h ago -
The Federal Reserve's preferred measure of inflation came in lower for August than it had in earlier months, but a recent methodology change raises questions about the strength of the signal.
4h ago -
New York Life's investment arm is buying a majority stake in Verus' parent, as higher rates draw insurers to non-QM. Lenders should expect deeper-pocketed buyers and competition.
September 29









